A Phase 3 Randomised, Double-Masked, Placebo-Controlled Study of the Effect of OMS302 on Intraoperative Pupil Diameter in Subjects at High Risk of Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement

Trial Profile

A Phase 3 Randomised, Double-Masked, Placebo-Controlled Study of the Effect of OMS302 on Intraoperative Pupil Diameter in Subjects at High Risk of Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement

Discontinued
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Ketorolac/phenylephrine (Primary)
  • Indications Intraoperative complications; Iris diseases
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Sponsors Omeros Corporation
  • Most Recent Events

    • 14 Aug 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 27 Mar 2014 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT02093689)
    • 03 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top